SeaCrest Wealth Management LLC cut its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 22.7% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,942 shares of the company's stock after selling 5,860 shares during the period. SeaCrest Wealth Management LLC's holdings in Procter & Gamble were worth $3,177,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently made changes to their positions in PG. Kingstone Capital Partners Texas LLC increased its holdings in shares of Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock valued at $11,832,680,000 after acquiring an additional 76,017,350 shares during the last quarter. Nuveen LLC acquired a new position in shares of Procter & Gamble during the 1st quarter valued at about $1,954,941,000. GAMMA Investing LLC increased its holdings in shares of Procter & Gamble by 20,758.5% during the 1st quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock valued at $1,355,087,000 after acquiring an additional 7,913,335 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after acquiring an additional 2,466,308 shares during the last quarter. Finally, Invesco Ltd. increased its holdings in shares of Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock valued at $2,299,580,000 after acquiring an additional 2,228,151 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Procter & Gamble Price Performance
PG traded down $1.17 during trading on Friday, hitting $156.15. The company's stock had a trading volume of 17,159,888 shares, compared to its average volume of 5,803,375. The firm's 50 day moving average price is $156.16 and its two-hundred day moving average price is $161.28. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 12 month low of $149.91 and a 12 month high of $180.43. The stock has a market capitalization of $365.47 billion, a price-to-earnings ratio of 23.99, a price-to-earnings-growth ratio of 4.12 and a beta of 0.36.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter in the previous year, the company posted $1.40 EPS. The business's revenue for the quarter was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Sell-side analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were paid a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is 64.98%.
Insider Buying and Selling
In other news, CEO Jennifer L. Davis sold 8,596 shares of Procter & Gamble stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,351,892.92. Following the completion of the sale, the chief executive officer directly owned 64,991 shares of the company's stock, valued at approximately $10,221,134.57. This trade represents a 11.68% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Sundar G. Raman sold 9,554 shares of Procter & Gamble stock in a transaction on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,511,060.64. Following the completion of the sale, the chief executive officer directly owned 41,886 shares of the company's stock, valued at $6,624,689.76. This trade represents a 18.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 120,181 shares of company stock worth $18,918,012. 0.20% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
A number of research analysts have recently commented on the company. Barclays set a $164.00 price objective on Procter & Gamble and gave the company an "equal weight" rating in a report on Thursday, July 31st. Evercore ISI reissued an "in-line" rating and set a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Berenberg Bank raised their target price on Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a report on Wednesday. BNP Paribas reaffirmed an "outperform" rating and issued a $177.00 target price on shares of Procter & Gamble in a report on Friday, August 15th. Finally, JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $170.00 target price (down previously from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, Procter & Gamble currently has an average rating of "Moderate Buy" and a consensus price target of $173.94.
Check Out Our Latest Stock Report on Procter & Gamble
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report